Kronos Bio, Inc. (KRON)

Last Closing Price: 1.24 (2024-03-27)

EBIT (Quarterly)

EBIT: Income before interest and taxes.

Kronos Bio, Inc. (KRON) had EBIT of $-33.83M for the most recently reported fiscal quarter, ending 2023-09-30.

Figures for fiscal quarter ending 2023-09-30
Income Statement Financials
$0.92M
$-31.37M
--
$0.92M
$34.74M
$-33.83M
$2.45M
$-31.37M
$-31.37M
$-31.37M
$-31.37M
$-31.37M
$-31.37M
EBIT
$-33.83M
$-34.68M
58.15M
58.15M
$-0.54
$-0.54
Balance Sheet Financials
$191.56M
$11.31M
$46.43M
$237.99M
$25.67M
--
$33.70M
$59.37M
$178.62M
$178.62M
$178.62M
58.18M
Cash Flow Statement Financials
$-53.56M
$34.81M
$0.38M
$78.00M
$59.62M
$-18.37M
$19.81M
--
--
Fundamental Metrics & Ratios
7.46
--
--
--
--
100.00%
-3688.66%
-3688.66%
--
-3421.37%
-3421.37%
$-54.21M
--
--
--
0.00
--
--
--
-17.56%
-17.56%
-13.18%
-17.56%
$3.07
$-0.93
$-0.92